Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 180

Results For "Medica"

2468 News Found

OPPI summit calls for collaboration across stakeholders
News | March 30, 2022

OPPI summit calls for collaboration across stakeholders

The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India


USFDA approves CartiHeal's implant for the treatment of cartilage and osteochondral defects
Drug Approval | March 30, 2022

USFDA approves CartiHeal's implant for the treatment of cartilage and osteochondral defects

Approval is based on results of a multicenter, randomized, open-labeled and controlled IDE clinical study that demonstrated the superiority of Agili-C™ implant to the current surgical standard of care, debridement and microfracture in the knee joint


NAMSA to acquire European-based Medanex clinic
Biotech | March 30, 2022

NAMSA to acquire European-based Medanex clinic

World-leading companies, as well as small innovative research groups, regularly partner with Medanex for their outstanding cardiovascular services and timely, efficacious study outcomes.


ASC Therapeutics gets green light to advance gene therapy for Hemophilia A
Biotech | March 30, 2022

ASC Therapeutics gets green light to advance gene therapy for Hemophilia A

A novel second-generation approach to achieve a safe, durable, and stable transgene expression to overcome the challenges of factor VIII replacement therapies


TDB approves funding for MIM in MedTech
News | March 30, 2022

TDB approves funding for MIM in MedTech

Technology Development Board supports commercialisation of Metal Injection Molding of implants


Ozempic 2.0 mg approved in the US for the treatment of type 2 diabetes
Drug Approval | March 29, 2022

Ozempic 2.0 mg approved in the US for the treatment of type 2 diabetes

Ozempic is now approved in the US at 0.5 mg,1.0 mg and 2.0 mg doses for the treatment of type 2 diabetes in adults


Dysval gets regulatory approval in Japan
Drug Approval | March 29, 2022

Dysval gets regulatory approval in Japan

Tardive dyskinesia (TD) is a movement disorder that is characterized by uncontrollable, abnormal and repetitive movements of the face, torso and/or other body parts, which may be disruptive and negatively impact patients


USFDA clears IND application for an intranasal RSV vaccine
Biotech | March 29, 2022

USFDA clears IND application for an intranasal RSV vaccine

The companies are now preparing to initiate a Phase 1 trial to assess the safety and immunogenicity of BLB-201 in healthy volunteers


Carestream Health India showcases two new products at IRIA
Medical Device | March 29, 2022

Carestream Health India showcases two new products at IRIA

As a partner with IRIA, the company had a significant booth presence on-ground during the conference.


Qure.ai raises US $ 40 million from healthcare investors Novo Holdings and HealthQuad
Digitisation | March 29, 2022

Qure.ai raises US $ 40 million from healthcare investors Novo Holdings and HealthQuad

The funding will accelerate the AI-driven healthcare company's market expansion into the global market and support new product development